Literature DB >> 3305862

Kinetics of hepatic transport of 4-methylumbelliferone in rats. Analysis by multiple indicator dilution method.

S Miyauchi, Y Sugiyama, Y Sawada, K Morita, T Iga, M Hanano.   

Abstract

Hepatic elimination of 4-methylumbelliferone (4-MU), which has been used as a model compound for conjugative metabolism, was studied by means of a multiple indicator dilution (MID) method in the isolated perfused rat liver. Using this method, three intrinsic hepatic clearances, CLint,inf, CLint,eff, and CLint,seq, which represent the influx, efflux, and sequestration processes, respectively, were obtained. When the dose was increased from a low dose (50 micrograms/rat liver) to a high dose (3000 micrograms/rat liver), the hepatic availability of 4-MU increased from 0.11 to 0.73. With increasing dose, the CLint,eff value increased approximately two times, while the CLint,seq value decreased to approximately one-third. The remarkable dose dependence of hepatic availability was due to nonlinearity in both CLint,eff and CLint,seq values. However, the CLint,inf value was almost independent of dose. The dose-dependent change in CLint,seq might be explained by the saturation of conjugative metabolism of 4-MU, while the increase in the CLint,eff value with increasing dose might be partly explained by the nonlinear tissue binding of 4-MU, since the tissue unbound fraction determined by an ultrafiltration method using liver homogenate increased approximately 1.5 times at higher concentration of 4-MU compared to that at lower concentrations. In addition, based on a comparison of the individual intrinsic clearances, i.e., CLint,inf, CLint,eff, and CLint,seq, the major determining process of the apparent hepatic intrinsic clearance of 4-MU is thought to be the sequestration process at the high dose. However, at the low dose, the membrane transport process (influx and efflux processes) as well as the sequestration process also determine the apparent hepatic intrinsic clearance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3305862     DOI: 10.1007/BF01062937

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  21 in total

1.  INITIAL DISTRIBUTION AND RATE OF UPTAKE OF SULFOBROMOPHTHALEIN IN THE LIVER.

Authors:  C A GORESKY
Journal:  Am J Physiol       Date:  1964-07

2.  Conjugation of various drugs in isolated hepatocytes.

Authors:  B Andersson; M Berggren; P Moldéus
Journal:  Drug Metab Dispos       Date:  1978 Nov-Dec       Impact factor: 3.922

3.  Capillary exchange modeling. Barrier-limited and flow-limited distribution.

Authors:  C A Goresky; W H Ziegler; G G Bach
Journal:  Circ Res       Date:  1970-11       Impact factor: 17.367

4.  Analysis of multiple indicator dilution curves for estimation of renal tubular transport parameters.

Authors:  Y Sawada; N Itoh; Y Sugiyama; T Iga; M Hanano
Journal:  Comput Methods Programs Biomed       Date:  1985-05       Impact factor: 5.428

5.  Protein binding and hepatic clearance: discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparation.

Authors:  M Rowland; D Leitch; G Fleming; B Smith
Journal:  J Pharmacokinet Biopharm       Date:  1984-04

6.  Hepatic clearance of drugs. II. Experimental evidence for acceptance of the "well-stirred" model over the "parallel tube" model using lidocaine in the perfused rat liver in situ preparation.

Authors:  K S Pang; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1977-12

7.  Uptake of materials by the intact liver. The exchange of glucose across the cell membranes.

Authors:  C A Goresky; B E Nadeau
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

8.  Effect of albumin on hepatic uptake of warfarin in normal and analbuminemic mutant rats: analysis by multiple indicator dilution method.

Authors:  S C Tsao; Y Sugiyama; Y Sawada; S Nagase; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1986-02

9.  Glucuronidation and sulfation in the rat in vivo. The role of the liver and the intestine in the in vivo clearance of 4-methylumbelliferone.

Authors:  G J Mulder; S Brouwer; J G Weitering; E Scholtens; K S Pang
Journal:  Biochem Pharmacol       Date:  1985-04-15       Impact factor: 5.858

10.  Pharmacokinetic study of 4-methylumbelliferone in rats: influence of dose on its first-pass hepatic elimination.

Authors:  K Morita; Y Sugiyama; M Hanano
Journal:  J Pharmacobiodyn       Date:  1986-02
View more
  14 in total

1.  Kinetic analysis of the dose-dependent hepatic handling of 1-anilino-8-naphthalene sulfonate in rats.

Authors:  Y B Chung; S Miyauchi; Y Sugiyama; H Harashima; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1990-08

2.  Availability predictions by hepatic elimination models for Michaelis-Menten kinetics.

Authors:  M S Roberts; J D Donaldson; D Jackett
Journal:  J Pharmacokinet Biopharm       Date:  1989-12

Review 3.  Prediction of hepatic clearance in human from in vitro data for successful drug development.

Authors:  Masato Chiba; Yasuyuki Ishii; Yuichi Sugiyama
Journal:  AAPS J       Date:  2009-04-30       Impact factor: 4.009

4.  Dynamic determination of kinetic parameters for the interaction between polypeptide hormones and cell-surface receptors in the perfused rat liver by the multiple-indicator dilution method.

Authors:  H Sato; Y Sugiyama; Y Sawada; T Iga; S Sakamoto; T Fuwa; M Hanano
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  Uptake is the rate-limiting step in the overall hepatic elimination of pravastatin at steady-state in rats.

Authors:  M Yamazaki; S Akiyama; R Nishigaki; Y Sugiyama
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

6.  Membrane transport in hepatic clearance of drugs. I: Extended hepatic clearance models incorporating concentration-dependent transport and elimination processes.

Authors:  Y Kwon; M E Morris
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

Review 7.  Receptor-mediated transport of peptide hormones and its importance in the overall hormone disposition in the body.

Authors:  Y Sugiyama; M Hanano
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

8.  When Does the Rate-Determining Step in the Hepatic Clearance of a Drug Switch from Sinusoidal Uptake to All Hepatobiliary Clearances? Implications for Predicting Drug-Drug Interactions.

Authors:  Gabriela I Patilea-Vrana; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2018-08-16       Impact factor: 3.922

9.  Kinetic analysis of albumin-mediated uptake of warfarin by perfused rat liver.

Authors:  S C Tsao; Y Sugiyama; Y Sawada; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1988-04

10.  Comparison of the hepatic uptake clearances of fifteen drugs with a wide range of membrane permeabilities in isolated rat hepatocytes and perfused rat livers.

Authors:  S Miyauchi; Y Sawada; T Iga; M Hanano; Y Sugiyama
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.